EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H19BrN4O2.C6H6O3S |
| Net Charge | 0 |
| Average Mass | 597.491 |
| Monoisotopic Mass | 596.07290 |
| SMILES | COC(=O)CC[C@@H]1N=C(c2ccccn2)c2cc(Br)ccc2-n2c(C)cnc21.O=S(=O)(O)c1ccccc1 |
| InChI | InChI=1S/C21H19BrN4O2.C6H6O3S/c1-13-12-24-21-17(7-9-19(27)28-2)25-20(16-5-3-4-10-23-16)15-11-14(22)6-8-18(15)26(13)21;7-10(8,9)6-4-2-1-3-5-6/h3-6,8,10-12,17H,7,9H2,1-2H3;1-5H,(H,7,8,9)/t17-;/m0./s1 |
| InChIKey | QMTKNJZIWGTNTE-LMOVPXPDSA-N |
| Roles Classification |
|---|
| Biological Roles: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| Applications: | analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. sedative A central nervous system depressant used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. anaesthetic Substance which produces loss of feeling or sensation. GABA modulator A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| remimazolam besylate (CHEBI:757803) has role anaesthetic (CHEBI:38867) |
| remimazolam besylate (CHEBI:757803) has role analgesic (CHEBI:35480) |
| remimazolam besylate (CHEBI:757803) has role sedative (CHEBI:35717) |
| remimazolam besylate (CHEBI:757803) is a benzodiazepine (CHEBI:22720) |
| Synonyms | Source |
|---|---|
| BIPRAZINE PF | ChEMBL |
| CNS 7056B | ChEMBL |
| CNS-7056B | ChEMBL |
| CNS 7056 besylate | ChEMBL |
| CNS-7056 BESYLATE | ChEMBL |
| GW-502056X | ChEMBL |
| Brand Name | Source |
|---|---|
| Byfavo | ChEMBL |